Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Top Sclerotherapy Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Sclerotherapy Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Detergents
1.3.3 Osmotic agents
1.3.4 Chemical irritants
1.4 Market Segment by Application
1.4.1 Global Sclerotherapy Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Venous disease
1.4.3 Gastrointestinal bleeding
1.4.4 Bronchopleural fistula
1.4.5 Cystic disease
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Sclerotherapy Revenue (2015-2026)
2.1.1 Global Sclerotherapy Revenue (2015-2026)
2.1.2 Global Sclerotherapy Sales (2015-2026)
2.2 Sclerotherapy Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Sclerotherapy Sales by Regions (2015-2020)
2.2.2 Global Sclerotherapy Revenue by Regions (2015-2020)
2.3 Global Top Sclerotherapy Regions (Countries) Ranking by Market Size
2.4 Sclerotherapy Industry Trends
2.4.1 Sclerotherapy Market Top Trends
2.4.2 Market Drivers
2.4.3 Sclerotherapy Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Sclerotherapy Players: Views for Future
3 Competitive Landscape by Manufacturers
3.1 Global Top Sclerotherapy Manufacturers by Sales (2015-2020)
3.1.1 Global Sclerotherapy Sales by Manufacturers (2015-2020)
3.1.2 Global Sclerotherapy Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Sclerotherapy Sales in 2019
3.2 Global Top Manufacturers Sclerotherapy by Revenue
3.2.1 Global Sclerotherapy Revenue by Manufacturers (2015-2020)
3.2.2 Global Sclerotherapy Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Sclerotherapy Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sclerotherapy as of 2019)
3.4 Global Sclerotherapy Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Sclerotherapy Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Sclerotherapy Market
3.7 Key Manufacturers Sclerotherapy Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Sclerotherapy Historic Market Review by Type (2015-2020)
4.1.2 Global Sclerotherapy Sales Market Share by Type (2015-2020)
4.1.3 Global Sclerotherapy Revenue Market Share by Type (2015-2020)
4.1.4 Sclerotherapy Price by Type (2015-2020)
4.1 Global Sclerotherapy Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Sclerotherapy Sales Forecast by Type (2021-2026)
4.2.3 Global Sclerotherapy Revenue Forecast by Type (2021-2026)
4.2.4 Sclerotherapy Price Forecast by Type (2021-2026)
5 Global Sclerotherapy Market Size by Application
5.1 Global Sclerotherapy Historic Market Review by Application (2015-2020)
5.1.2 Global Sclerotherapy Sales Market Share by Application (2015-2020)
5.1.3 Global Sclerotherapy Revenue Market Share by Application (2015-2020)
5.1.4 Sclerotherapy Price by Application (2015-2020)
5.2 Global Sclerotherapy Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Sclerotherapy Sales Forecast by Application (2021-2026)
5.2.3 Global Sclerotherapy Revenue Forecast by Application (2021-2026)
5.2.4 Sclerotherapy Price Forecast by Application (2021-2026)
6 North America
6.1 North America Sclerotherapy Breakdown Data by Company
6.2 North America Sclerotherapy Breakdown Data by Type
6.3 North America Sclerotherapy Breakdown Data by Application
6.4 North America Sclerotherapy Breakdown Data by Countries
6.4.1 North America Sclerotherapy Sales by Countries
6.4.2 North America Sclerotherapy Revenue by Countries
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Sclerotherapy Breakdown Data by Company
7.2 Europe Sclerotherapy Breakdown Data by Type
7.3 Europe Sclerotherapy Breakdown Data by Application
7.4 Europe Sclerotherapy Breakdown Data by Countries
7.4.1 Europe Sclerotherapy Sales by Countries
7.4.2 Europe Sclerotherapy Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Sclerotherapy Breakdown Data by Company
8.2 Asia Pacific Sclerotherapy Breakdown Data by Type
8.3 Asia Pacific Sclerotherapy Breakdown Data by Application
8.4 Asia Pacific Sclerotherapy Breakdown Data by Regions
8.4.1 Asia Pacific Sclerotherapy Sales by Regions
8.4.2 Asia Pacific Sclerotherapy Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Sclerotherapy Breakdown Data by Company
9.2 Latin America Sclerotherapy Breakdown Data by Type
9.3 Latin America Sclerotherapy Breakdown Data by Application
9.4 Latin America Sclerotherapy Breakdown Data by Countries
9.4.1 Latin America Sclerotherapy Sales by Countries
9.4.2 Latin America Sclerotherapy Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sclerotherapy Breakdown Data by Type
10.2 Middle East and Africa Sclerotherapy Breakdown Data by Application
10.3 Middle East and Africa Sclerotherapy Breakdown Data by Countries
10.3.1 Middle East and Africa Sclerotherapy Sales by Countries
10.3.2 Middle East and Africa Sclerotherapy Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E
11 Company Profiles
11.1 BTG
11.1.1 BTG Corporation Information
11.1.2 BTG Business Overview and Total Revenue (2019 VS 2018)
11.1.3 BTG Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 BTG Sclerotherapy Products and Services
11.1.5 BTG SWOT Analysis
11.1.6 BTG Recent Developments
11.2 Kreussler
11.2.1 Kreussler Corporation Information
11.2.2 Kreussler Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Kreussler Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Kreussler Sclerotherapy Products and Services
11.2.5 Kreussler SWOT Analysis
11.2.6 Kreussler Recent Developments
11.3 LGM Pharma
11.3.1 LGM Pharma Corporation Information
11.3.2 LGM Pharma Business Overview and Total Revenue (2019 VS 2018)
11.3.3 LGM Pharma Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 LGM Pharma Sclerotherapy Products and Services
11.3.5 LGM Pharma SWOT Analysis
11.3.6 LGM Pharma Recent Developments
11.4 Troikaa
11.4.1 Troikaa Corporation Information
11.4.2 Troikaa Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Troikaa Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Troikaa Sclerotherapy Products and Services
11.4.5 Troikaa SWOT Analysis
11.4.6 Troikaa Recent Developments
11.5 Changan Tianyu group
11.5.1 Changan Tianyu group Corporation Information
11.5.2 Changan Tianyu group Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Changan Tianyu group Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Changan Tianyu group Sclerotherapy Products and Services
11.5.5 Changan Tianyu group SWOT Analysis
11.5.6 Changan Tianyu group Recent Developments
11.6 Bioniche Pharma Group Ltd
11.6.1 Bioniche Pharma Group Ltd Corporation Information
11.6.2 Bioniche Pharma Group Ltd Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Bioniche Pharma Group Ltd Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Bioniche Pharma Group Ltd Sclerotherapy Products and Services
11.6.5 Bioniche Pharma Group Ltd SWOT Analysis
11.6.6 Bioniche Pharma Group Ltd Recent Developments
11.7 Omega Pharmaceuticals
11.7.1 Omega Pharmaceuticals Corporation Information
11.7.2 Omega Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Omega Pharmaceuticals Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Omega Pharmaceuticals Sclerotherapy Products and Services
11.7.5 Omega Pharmaceuticals SWOT Analysis
11.7.6 Omega Pharmaceuticals Recent Developments
11.8 Angiodynamics
11.8.1 Angiodynamics Corporation Information
11.8.2 Angiodynamics Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Angiodynamics Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Angiodynamics Sclerotherapy Products and Services
11.8.5 Angiodynamics SWOT Analysis
11.8.6 Angiodynamics Recent Developments
11.9 ENDO-FLEX
11.9.1 ENDO-FLEX Corporation Information
11.9.2 ENDO-FLEX Business Overview and Total Revenue (2019 VS 2018)
11.9.3 ENDO-FLEX Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 ENDO-FLEX Sclerotherapy Products and Services
11.9.5 ENDO-FLEX SWOT Analysis
11.9.6 ENDO-FLEX Recent Developments
11.10 MTW ENDOSKOPIE
11.10.1 MTW ENDOSKOPIE Corporation Information
11.10.2 MTW ENDOSKOPIE Business Overview and Total Revenue (2019 VS 2018)
11.10.3 MTW ENDOSKOPIE Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 MTW ENDOSKOPIE Sclerotherapy Products and Services
11.10.5 MTW ENDOSKOPIE SWOT Analysis
11.10.6 MTW ENDOSKOPIE Recent Developments
11.11 Cook Medical
11.11.1 Cook Medical Corporation Information
11.11.2 Cook Medical Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Cook Medical Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Cook Medical Sclerotherapy Products and Services
11.11.5 Cook Medical SWOT Analysis
11.11.6 Cook Medical Recent Developments
12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Sclerotherapy Sales Channels
12.2.2 Sclerotherapy Distributors
12.3 Sclerotherapy Customers
13 Estimates and Projections by Regions (2021-2026)
13.1 Global Sclerotherapy Sales Forecast (2021-2026)
13.1.1 Global Sclerotherapy Sales Forecast by Regions (2021-2026)
13.1.2 Global Sclerotherapy Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Sclerotherapy Sales Forecast (2021-2026)
13.2.2 North America Sclerotherapy Revenue Forecast (2021-2026)
13.2.3 North America Sclerotherapy Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Sclerotherapy Sales Forecast (2021-2026)
13.3.2 Europe Sclerotherapy Revenue Forecast (2021-2026)
13.3.3 Europe Sclerotherapy Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Sclerotherapy Sales Forecast (2021-2026)
13.4.2 Asia Pacific Sclerotherapy Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Sclerotherapy Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Sclerotherapy Sales Forecast (2021-2026)
13.5.2 Latin America Sclerotherapy Revenue Forecast (2021-2026)
13.5.3 Latin America Sclerotherapy Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Sclerotherapy Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Sclerotherapy Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Sclerotherapy Size Forecast by County (2021-2026)
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
【掲載企業】
BTG、Kreussler、LGM Pharma、Troikaa、Changan Tianyu group、Bioniche Pharma Group Ltd、Omega Pharmaceuticals、Angiodynamics、ENDO-FLEX、MTW ENDOSKOPIE、Cook Medical
【免責事項】
https://www.globalresearch.jp/disclaimer